Skip to main
DD

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours has demonstrated robust organic sales growth in its Healthcare & Water business, attributed to strong demand in medical packaging, biopharma, and reverse osmosis, positioning it favorably in a lucrative market. The company's focused shift towards new products, as indicated by its vitality index improvement goals, suggests potential for enhanced price and mix dynamics, which could positively impact profitability in the coming years. Additionally, the Electronics & Industrial segment anticipates growth from advancements in technology and infrastructure, such as 5G and IoT, contributing to a favorable long-term outlook for DuPont's valuation as it undergoes a significant portfolio transformation.

Bears say

The financial outlook for DuPont de Nemours is challenged by anticipated delays in synergy realization stemming from the DowDuPont merger, which may hinder operational efficiency and growth potential. Additionally, persistent weakness in the electronics and construction markets is expected to adversely affect revenue generation in these key sectors. Lastly, the slow recovery in the Chinese market further compounds the difficulties the company faces, impacting overall profitability and market performance.

DD has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 11 analysts, DD has a Buy consensus rating as of Dec 31, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.